We attributed this incomplete protection seen in CD200-/- mice to an ongoing immunosuppression by tumor rather than host-expressed CD200 [4]-see also decreased CTL in CD200-/- (compared with CD200R-/-) mice in Fig 5A. This evidence concerns the gene CD200R1 and neoplasm.